Novartis has bought Vedere Bio, a retinal disease therapy spinout of UC Berkeley also exploiting UPenn research, to expand its gene medicine capabilities.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Alexis Dormandy will join Oxford Sciences Innovation as chief executive, moving over from Atomico by January 2021 to take over from interim CEO Jim Wilkinson.

Banco Sabadell looks likely to have exited the digital signature software provider after Providence Equity Partners bought a majority stake.

Exact Sciences has shelled out $410m to buy University of Oxford early cancer test company Base Genomics, incorporated in July 2019.

Cybersecurity consulting services provider SEC Consult has agreed to be purchased in a deal that will allow Swisscom Ventures to exit.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Q&A with Ore Adeyemi, managing director and head, HSBC SII

Aalto's bone lengthening treatment spinout Synoste has been snapped up after raising funding from investors including Evonik and Mectalent.

Parkwalk made the revelations in a bullish quarterly update that cited the UK government's interest in invigorating deep tech research amid covid-19.